Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Maria De Santis

31PUBLICATIONS
196CO-AUTHORS
Rheumatology and arthritisAutoimmunityImmunogenetics (incl. genetic immunology)Medical microbiology not elsewhere classifiedMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

Sort by Publication Date:
|Jun 15, 2026
Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

|May 13, 2026
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.

|Apr 05, 2026
Real-world application of the international myositis assessment and clinical studies group guidelines on cancer risk stratification.

Maria Rosa Pellico, Cristina Bochicchio, Claudia Iannone

|Mar 05, 2026
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort.

Liala Moschetti, Silvia Rovaris, Francesco Bonomi

|Dec 30, 2025
Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry.

Enrico De Lorenzis, Gerlando Natalello, Rossella De Angelis

|Sep 27, 2025
Detection and Clinical Associations of Autoantibodies to Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A2/B1 in Patients with Systemic Sclerosis.

Antonio Tonutti, Natasa Isailovic, Lukas Frischknecht

Pageof 6

Frequent Collaborators

13 joint publications

Carlo Selmi

8 joint publications

Fabio Cacciapaglia

8 joint publications

Giacomo De Luca

7 joint publications

Corrado Campochiaro

7 joint publications

Florenzo Iannone

6 joint publications

Edoardo Rosato

6 joint publications

Antonio Tonutti

5 joint publications

Andrea Doria

4 joint publications

Salvatore D'Angelo

4 joint publications

Alarico Ariani

Frequent Collaborators

13 joint publications

Carlo Selmi

8 joint publications

Fabio Cacciapaglia

8 joint publications

Giacomo De Luca

7 joint publications

Corrado Campochiaro